Information de reference pour ce titreAccession Number: | 00006534-201103000-00044.
|
Author: | Neuhann-Lorenz, Constance M.D.; Fedeles, Josef M.D.; Eisenman-Klein, Marita M.D.; Kinney, Brian M.D.; Cunningham, Bruce L. M.D., M.Sc.
|
Institution: | Munich and Regensburg, Germany; Bratislava, Slovakia; Los Angeles, Calif.; and Minneapolis, Minn.
|
Title: | |
Source: | Plastic & Reconstructive Surgery. 127(3):1368-1375, March 2011.
|
Abstract: | Background: On April 7, 2009, the International Committee for Quality Assurance, Medical Technologies and Devices in Plastic Surgery (IQUAM) issued its 8th Position Statement. IQUAM is a professional medical and scientific organization committed to the surveillance of existing and new technologies and devices in plastic surgery. IQUAM periodically reviews and evaluates updated international literature and studies and scientific data, and recommends standards of treatment for plastic surgery devices and technologies. IQUAM proscribes potentially deleterious use of products, devices, and technologies, or their unintended application or application for unsuitable indications.
Methods: Presentations of an international panel of experts made during the Transatlantic Innovations Symposia in Paris, in April of 2009, were reviewed by an advisory board that prepared the position statement for distribution to plastic surgeons and regulatory bodies. The advisory panel was international in nature and included plastic surgeons with expertise in the specific areas evaluated.
Results: Three clinical areas of greatest concern to plastic surgeons were evaluated for efficacy and safety: silicone breast implants, tissue engineering, and injectable therapies.
Conclusion: Specific recommendations designed to increase clinical safety and patient education for informed consent were made in each area.
(C)2011American Society of Plastic Surgeons
|
References: | 1. Chekaroua K, Trevidic P, Foyatier JL, Comparin JP, Delay E. Postoperative complications after breast implantation [in French]. Ann Chir Plast Esthet. 2005;50:544-553.
2. Dionyssopoulos A. The non-perfect results of breast implants [in French]. Ann Chir Plast Esthet. 2005;50:534-543.
3. Handel N, Jensen JA, Black Q, Waisman JR, Silverstein MJ. The fate of breast implants: A critical analysis of complications and outcomes. Plast Reconstr Surg. 1995;96:1521-1533.
4. Gabriel SE, Woods JE, O'Fallon FM, et al. Complications leading to surgery after breast implantation. N Engl Med. 1997;336:677-678.
5. Zhu H, Lin W, Quan G. An analysis of complications after implantation of saline-filled silicone prosthesis for augmentation mammaplasty in 294 cases. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 1995;11:248-250.
6. Institute of Medicine. Safety of silicone breast implants. National Academy of Sciences, 1999. Available at: http://iom.edu/Reports/1999/Safe...- ouverture dans une nouvelle fenêtre. Accessed February 2, 2011.
7. Medicines and Healthcare Products Regulatory Agency. Independent Review Group: Silicone Gel Breast Implants. p 25. Available at: http://www.silicone-review.gov.u...- ouverture dans une nouvelle fenêtre. Accessed February 2, 2011.
8. European Parliament Directorate General for Research, Scientific and Technological Options Assessment. Health risks posed by silicone implants in general with special attention to breast implants: Final study. pp 22-23. European Parliament Resolution on the petitions declared admissible concerning silicone implants (Petitions nos. 470/1998 and 771/1998) (2001/2068[INI]). Available at: http://www.europarl.europa.eu/st...- ouverture dans une nouvelle fenêtre. Accessed March 22, 2010.
9. Health Council of the Netherlands. Gezondheidsrisico's van siliconen-borstimplantaten-Health Risks of Silicone Breast Implants: English Executive Summary. p 11. Available at: http://www.gezondheidsraad.nl- ouverture dans une nouvelle fenêtre. Accessed February 2, 2011.
10. Cunningham B. The Mentor Study on Contour Profile Gel Silicone MemoryGel Breast Implants. Plast Reconstr Surg. 2007;120(7 Suppl 1):33S-39S.
11. Spear SL, Murphy DK, Slicton A, Walker PS; Inamed Silicone Breast Implant U.S. Study Group. Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg. 2007;120(7 Suppl 1):8S-16S; discussion 17S-18S.
12. Medicines and Healthcare Products Regulatory Agency. Independent Review Group: Silicone Gel Breast Implants. p 24. Available at: http://www.silicone-review.gov.u...- ouverture dans une nouvelle fenêtre. Accessed February 2, 2011.
13. European Parliament Directorate General for Research, Scientific and Technological Options Assessment. Health risks posed by silicone implants in general with special attention to breast implants: Final study. European Parliament Resolution on the petitions declared admissible concerning silicone implants (petitions nos. 470/1998 and 771/1998) (2001/2068[INI]). pp 25-26. Available at: http://ec.europa.eu/enterprise/m...- ouverture dans une nouvelle fenêtre. Accessed March 22, 2010.
14. Health Council of the Netherlands. Gezondheidsrisico's van siliconen-borstimplantaten-Health Risks of Silicone Breast Implants: English Executive Summary. p 34. Available at: http://www.gezondheidsraad.nl- ouverture dans une nouvelle fenêtre. Accessed February 2, 2011.
15. Boyd JB, Gelfand M, Da Lio A, Shaw W, Watson JP. Comparison of superior gluteal artery musculocutaneous and superior gluteal artery perforator flaps for microvascular breast reconstruction. Plast Reconstr Surg. 2009;123:1641-1647.
16. Gusenoff JA, Coon D, de la Cruz C, Rubin JP, Watson JP. Superficial inferior epigastric vessels in the massive weight loss population: Implications for breast reconstruction. Plast Reconstr Surg. 2008;122:1621-1626.
17. Schirmer S, Warnecke IC, Frerichs O, Cervelli A, Fansa H. Alternative autologous breast reconstruction using the free microvascular gracilis muscle flap with horizontal skin island. Handchir Mikrochir Plast Chir. 2008;40:262-266.
18. Serletti JM. Breast reconstruction with the TRAM flap: Pedicled and free. J Surg Oncol. 2006;94:532-537.
19. Blondeel PN. One hundred free DIEP flap breast reconstructions: A personal experience. Br J Plast Surg. 1999;52:104-111.
20. Coleman SR, Saboeiro AP. Fat grafting to the breast revisited: Safety and efficacy. Plast Reconstr Surg. 2007;119:775-785; discussion 786-787.
21. Smith CJ, Khouri RK, Baker TJ. Initial experience with the Brava nonsurgical system of breast enhancement. Plast Reconstr Surg. 2000;105:2500-2512; discussion 2513-2514.
22. Schlenz I, Kaider A. The Brava external tissue expander: Is breast enlargement without surgery a reality? Plast Reconstr Surg. 2007;120:1680-1689; discussion 1690-1691.
23. Zocchi ML, Zuliani F. Bicompartmental breast lipostructuring. Aesthetic Plast Surg. 2008;32:313-328.
24. Heden P, Sellman G, von Wachenfeldt M, Olenius M, Fagrell D. Body shaping and volume restoration: The role of hyaluronic acid. Aesthetic Plast Surg. 2009;33:274-282.
25. European Parliament Committee on the Environment, Public Health and Consumer Policy. On the communication from the Commission on community and national measures in relation to breast implants (COM(2001) 666-C5-0327/2002-2002/2171(COS)). January 23, 2003. Available at: http://www.europarl.europa.eu/si...- ouverture dans une nouvelle fenêtre. Accessed February 2, 2011.
26. European Parliament Texts Adopted by Parliament Provisional Edition: Commission Directive 2003/12/EC of 3 February 2003 on the reclassification of breast implants in the framework of Directive 93/42/EEC concerning medical devices (Text with EEA relevance). Available at: http://eur-lex.europa.eu/LexUriS...- ouverture dans une nouvelle fenêtre. Accessed February 2, 2011.
27. Rigotti G, Marchi A, Sbarbati A. Adipose-derived mesenchymal stem cells: Past, present and future. Aesthetic Plast Surg. 2009;33:271-273.
28. Cherubino M, Marra KG. Adipose-derived stem cells for soft tissue reconstruction. Regen Med. 2009;4:109-117.
29. Raff M. Adult stem cell plasticity: Fact or artifact? Annu Rev Cell Dev Biol. 2003;19:1-22.
30. Edwards RG. Stem cells today: A. Origin and potential of embryo stem cells. Reprod Biomed Online 2004;8:275-306.
31. Mojallal A, Foyatier JL. Historical review of the use of adipose tissue transfer in plastic and reconstructive surgery (in French). Ann Chir Plast Esthet. 2004;49:419-425.
32. Beier JP, Klumpp D, Rudisile M, et al. Collagen matrices from sponge to nano: New perspectives for tissue engineering of skeletal muscle. BMC Biotechnol. 2009;9:34.
33. Gregory CA, Ylostalo J, Prockop DJ. Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: A two-stage hypothesis for regulation of MSC fate. Sci STKE. 2005;(294):pe37.
34. Stillaert FB, Di Bartolo C, Hunt JA, Rhodes NP, Tognana E, Monstrey S, Blondeel PN. Human clinical experience with adipose precursor cells seeded on hyaluronic acid-based spongy scaffolds. Biomaterials 2008;29:3953-3959.
35. Stillaert FB, Blondeel P, Hamdi M, Abberton K, Thompson E, Morrison WA. Adipose tissue induction in vivo. Adv Exp Med Biol. 2006;585:403-412.
36. Lokmic Z, Stillaert F, Morrison WA, Thompson EW, Mitchell GM. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J. 2007;21:511-522.
37. Occleston NL, O'Kane S, Goldspink N, Ferguson MW. New therapeutics for the prevention and reduction of scarring. Drug Discov Today 2008;13:973-981.
38. Occleston NL, Laverty HG, O'Kane S, Ferguson MW. Prevention and reduction of scarring in the skin by transforming growth factor beta 3 (TGFbeta3): From laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed. 2008;19:1047-1063.
39. Gimenez Garcia MC, Lliorente de la Fuente A. Soft tissue treatment. In: Coombs R, Shade W, Zhou S, eds. Musculoskeletal Shockwave Therapy. London: Greenwich Medical Media; 2000:25-32.
40. Goh P III. Clinical outcome of ESWT for selected chronic tendinopathies in physically active subjects (Abstract). Paper presented at: 3rd International Congress of the International Society for Musculoskeletal Shockwave Therapy; June 1-3, 2000; Naples, Italy.
41. Schaden W, Thiele R, Kolpl C, et al. Shock wave therapy for acute and chronic soft tissue wounds: A feasibility study. J Surg Res. 2007;143:1-12.
42. Ablon G, Rotunda AM. Treatment of lower eyelid fat pads using phosphatidylcholine: Clinical trial and review. Dermatol Surg. 2004;30:422-427; discussion 428.
43. Bates B. 'Fat dissolving' substance injects CCs of controversy. Skin Allergy News 2003;34:1.
44. Young VL. Lipostabil: The effect of phosphatidylcholine on subcutaneous fat. Aesthet Surg J. 2003;23:413-417.
45. Klein SM, Prantl L, Berner A, et al. A new method to quantify the effect after subcutaneous injection of lipolytic substances. Aesthetic Plast Surg. 2008;32:667-672; discussion 673-674.
46. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg. 2007;33(Suppl 2):S168-S175.
47. Dayan SH, Bassichis BA. Facial dermal fillers: Selection of appropriate products and techniques. Aesthet Surg J. 2008;28:335-347.
48. Smith KC. Reversible vs. nonreversible fillers in facial aesthetics: Concerns and considerations. Dermatol Online J. 2008;14:3.
49. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg. 2008;34(Suppl 1):S92-S99.
50. Reytan N, Rzany B. Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment. J Drugs Dermatol. 2008;7:884-886.
51. Matarasso SL. The use of injectable collagens for aesthetic rejuvenation. Semin Cutan Med Surg. 2006;25:151-157.
52. Monstrey SJ, Pitaru S, Hamdi M, et al. A two-stage phase I trial of Evolence30 collagen for soft-tissue contour correction. Plast Reconstr Surg. 2007;120:303-311.
53. Baumann LS, Shamban AT, Lupo MP, et al. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: A multicenter, double-masked, randomized, within-subject study. Dermatol Surg. 2007;33(Suppl 2):S128-S135.
54. Lupo MP, Smith SR, Thomas JA, Murphy CK, Beddingfield FC III. Effectiveness of Juvederm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg. 2008;121:289-297.
55. Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther. 2008;10:35-42.
56. Zhao XB, Fraser JE, Alexander C, Lockett C, White BJ. Synthesis and characterization of a novel double crosslinked hyaluronan hydrogel. J Mater Sci Mater Med. 2002;13:11-16.
57. Meyer K, Palmer JW. The polysaccharide of the vitreous humor. J Biol Chem. 1934;107:629-634.
58. Campoccia D, Doherty P, Radice M, Brun P, Abatangelo G, Williams DF. Semisynthetic resorbable materials from hyaluronan esterification biomaterials. Biomaterials 1998;19:2101-2127.
59. DeBelder AN, Malson T. Method of preventing adhesion between body tissues, means for preventing such adhesion, and process for producing said means. US patent 4,886,787. December 12, 1989.
60. Zhao XB, Alexander C, Fraser J. Process for cross-linking hyaluronic acid to polymers. US patent 7,226,972. June 5, 2007.
61. Kablik J, Monheit GD, Yu L, Chang G, Gershkovich J. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009;35(Suppl):302-312.
62. U.S. Food and Drug Administration. Restylane Injectable Gel-P020023: Labeling Information and Approval Letter. December 12, 2003.
63. U.S. Food and Drug Administration. Juvederm 30, Juvederm 24HV and Juvederm 30HV Injectable Dermal Filler-P050047: Labeling Information and Approval Letter. June 2, 2006.
64. Cheng NX, Wang YL, Wang JH, Zhang XM, Zhong H. Complications of breast augmentation with injected hydrophilic polyacrylamide gel. Aesthetic Plast Surg. 2002;26:375-382.
65. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg. 2007;33(Suppl 2):S168-S175.
66. Zarini E, Supino R, Pratesi G, et al. Biocompatibility and tissue interactions of a new filler material for medical use. Plast Reconstr Surg. 2004;114:934-942.
67. Fernandez-Cossio S, Castano-Oreja MT. Biocompatibility of two novel dermal fillers: Histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler. Plast Reconstr Surg. 2006;117:1789-1796.
68. De Santis G, Jacob A, Baccarani A, et al. Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: A 2-year clinical experience. Plast Reconstr Surg. 2008;121:644-653.
69. von Buelow S, Pallua N. Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation in a 2-year follow-up: A prospective multicenter study for evaluation of safety and aesthetic results in 101 patients. Plast Reconstr Surg. 2006;118(3 Suppl):85S-91S.
70. Manafi A, Emami AH, Pooli AH, Habibi M, Saidian L. Unacceptable results with an accepted soft tissue filler: Polyacrylamide hydrogel. Aesthetic Plast Surg. 2010;34:413-422.
71. Reda-Lari A. Augmentation of the malar area with polyacrylamide hydrogel: Experience with more than 1300 patients. Aesthet Surg J. 2008;28:131-138.
72. El-Shafey el-SI. Complications from repeated injection or puncture of old polyacrylamide gel implant sites: Case reports. Aesthetic Plast Surg. 2008;32:162-165.
73. Cohen SR, Berner CF, Busso M, et al. ArteFill: A long-lasting injectable wrinkle filler material-Summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Plast Reconstr Surg. 2006;118(3 Suppl):64S-76S.
74. Stark GB, Bannasch H. The "golden thread lift": Radiologic findings. Aesthetic Plast Surg. 2007;31:206-208.
|
Language: | English.
|
Document Type: | Special Topics: Special Topics.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0032-1052
|
NLM Journal Code: | 1306050, p9s
|
DOI Number: | https://dx.doi.org/10.1097/PRS.0...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|